View |
|
DR-XY41718
|
Water For Injection
|
None
|
None
|
Solution for Injection (IV)
|
Rehydration Solution (Parenteral)
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Initial (Variation)
|
30 August 2022
|
30 August 2027
|
View |
|
DR-XY41721
|
Clarithromycin
|
Myzin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
19 February 2023
|
21 February 2028
|
View |
|
DR-XY41725
|
Amphotericin B
|
Amfucin
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
-
|
U Square Lifesciences Pvt. Ltd.
|
India
|
-
|
28 September 2020
|
17 June 2025
|
View |
|
DR-XY41726
|
Ambroxol Hydrochloride
|
Mucosolvan 24Hrs
|
75 mg
|
Sustained Release Capsule
|
Mucolytic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Automatic Renewal
|
20 January 2023
|
28 February 2028
|
View |
|
DR-XY41729
|
Clarithromycin
|
Macromycin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 March 2023
|
28 February 2028
|
View |
|
DR-XY41735
|
Iopamidol
|
RADISENSE 300
|
612mg/mL (Equivalent to 300mg Iodine)
|
Solution For (Iv) Injection
|
-
|
Taejoon Pharm. Co., Ltd.
|
Korea
|
-
|
06 December 2019
|
27 February 2025
|
View |
|
DR-XY41743
|
L-Ornithine-L-Aspartate
|
Hepa-Merz
|
5g/10mL
|
Concentrate Solution For I.V. Infusion
|
Hepatic Protectant
|
B. Braun Melsungen Ag
|
Germany
|
Automatic Renewal
|
31 December 2022
|
22 February 2028
|
View |
|
DR-XY41745
|
Calcipotriol (as Monohydrate) + Betamethasone (as
dipropionate)
|
Daivobet
|
50 mcg/500 mcg per gram
|
Topical Gel
|
-
|
Leo Laboratories Ltd.
|
Ireland
|
Automatic Renewal (Reconstruction)
|
01 December 2022
|
21 January 2025
|
View |
|
DR-XY41746
|
Sodium Chloride
|
Breathe Ezy
|
0.0065
|
Buffered Solution Nasal Spray
|
Nasal Decongestant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 January 2022
|
25 February 2028
|
View |
|
DR-XY41747
|
Clopidogrel
|
Clopate
|
75 mg
|
Film Coated tablet
|
Antithrombotic / Antiplatelet
|
Unicure Remedies Pvt. Ltd.
|
India
|
Automatic Renewal
|
03 January 2023
|
25 February 2028
|
View |
|
DR-XY41749
|
Sodium Chloride
|
Breathe Ezy
|
0.0065
|
Buffered Solution Nasal Drops
|
Irrigating Solution
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
07 December 2022
|
25 February 2028
|
View |
|
DR-XY41756
|
Salbutamol (as sulfate)
|
Ventolax
|
200 mcg
|
Dry powder for Inhalation
|
Bronchodilator
|
Jewim Pharmaceutical (Shandong) Co., Ltd.
|
China
|
Renewal
|
22 March 2023
|
01 April 2028
|
View |
|
DR-XY41760
|
Ibuprofen
|
Medicol Advance 400
|
400 mg
|
Softgel Capsule
|
-
|
Belmont Softgel Pharma Corporation
|
Philippines
|
Initial (Variation)
|
21 July 2022
|
06 June 2027
|
View |
|
DR-XY41764
|
Multivitamins +Minerals
|
Rejuvon Ob Forte
|
|
Capsule
|
Vitamins/Minerals
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 March 2023
|
08 March 2028
|
View |
|
DR-XY41769
|
Budesonide
|
Nasoride
|
64mcg per actuation
|
Aqueous Nasal Spray
|
Corticosteroid (Glucocorticoid)
|
Jewim Pharmaceutical (Shandong) Co., Ltd.
|
China
|
Automatic Renewal
|
23 April 2021
|
07 March 2025
|
View |
|
DR-XY41771
|
Paclitaxel
|
Intaxel
|
6mg/mL
|
Concentrate Sterile Solution For Iv Infusion
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Fresenius Kabi Oncology Ltd.
|
India
|
Automatic Renewal
|
18 January 2023
|
07 March 2028
|
View |
|
DR-XY41773
|
Gemcitabine (As Hydrochloride)
|
Gemita
|
200 mg
|
Lyophilized Powder for Injection for IV Infusion
|
Antineoplastic Agent (Pyrimidine Analogue)
|
Fresenius Kabi Oncology Limited
|
India
|
Automatic Renewal
|
23 April 2021
|
11 March 2026
|
View |
|
DR-XY41774
|
Gemcitabine (As Hydrochloride)
|
Gemita
|
1 g
|
Lyophilized Powder for Injection for IV Infusion
|
Antineoplastic Agent (Pyrimidine Analogue)
|
Fresenius Kabi Oncology Limited
|
India
|
Automatic Renewal
|
23 March 2021
|
11 March 2026
|
View |
|
DR-XY41775
|
Irinotecan Hydrochloride Trihydrate
|
Irican
|
20 mg/mL
|
Solution for Injection (I.V Infusion)
|
-
|
Fresenius Kabi Oncology Limited
|
India
|
-
|
07 March 2022
|
11 March 2026
|
View |
|
DR-XY41777
|
Salicylic Acid + Lactic Acid
|
Corncallus
|
6.0 g/ 2.0 g per 100 mL
|
Solution
|
Keratolytic
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
Automatic Renewal
|
23 March 2021
|
18 March 2026
|